| Year |
Citation |
Score |
| 2024 |
Nguyen V, Schrank TP, Major MB, Weissman BE. ARID1A loss is associated with increased NRF2 signaling in human head and neck squamous cell carcinomas. Plos One. 19: e0297741. PMID 38358974 DOI: 10.1371/journal.pone.0297741 |
0.316 |
|
| 2024 |
Hamad SH, Sellers RS, Wamsley N, Zolkind P, Schrank TP, Major MB, Weissman BE. NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma. Cancer Research Communications. 4: 487-495. PMID 38335300 DOI: 10.1158/2767-9764.CRC-23-0386 |
0.344 |
|
| 2023 |
Nguyen VT, Tessema M, Weissman BE. The SWI/SNF Complex: A Frequently Mutated Chromatin Remodeling Complex in Cancer. Cancer Treatment and Research. 190: 211-244. PMID 38113003 DOI: 10.1007/978-3-031-45654-1_7 |
0.311 |
|
| 2023 |
Walhart TA, Vacca B, Hepperla JA, Hamad SH, Petrongelli J, Wang Y, McKean LE, Moksa M, Cao Q, Yip S, Hirst M, Weissman BE. SMARCB1 Loss in Poorly Differentiated Chordomas Drives Tumor Progression. The American Journal of Pathology. PMID 36657718 DOI: 10.1016/j.ajpath.2022.12.012 |
0.415 |
|
| 2022 |
Hamad SH, Montgomery SA, Simon JM, Bowman BM, Spainhower KB, Murphy RM, Knudsen ES, Fenton SE, Randell SH, Holt JR, Hayes DN, Witkiewicz AK, Oliver TG, Major MB, Weissman BE. TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice. Oncogene. PMID 35577980 DOI: 10.1038/s41388-022-02348-0 |
0.372 |
|
| 2020 |
Orlando KA, Douglas AK, Abudu A, Wang Y, Tessier-Cloutier B, Su W, Peters A, Sherman LS, Moore R, Nguyen V, Negri GL, Colborne S, Morin GB, Kommoss F, Lang JD, ... ... Weissman BE, et al. Re-expression of SMARCA4/BRG1 in Small Cell Carcinoma of Ovary, Hypercalcemic Type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism. Elife. 9. PMID 33355532 DOI: 10.7554/eLife.59073 |
0.475 |
|
| 2020 |
Karnezis AN, Chen SY, Chow C, Yang W, Hendricks WPD, Ramos P, Briones N, Mes-Masson AM, Bosse T, Gilks CB, Trent JM, Weissman B, Huntsman DG, Wang Y. Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines. Gynecologic Oncology. PMID 33328126 DOI: 10.1016/j.ygyno.2020.12.004 |
0.332 |
|
| 2020 |
Song S, Nguyen V, Schrank T, Mulvaney K, Walter V, Wei D, Orvis T, Desai N, Zhang J, Hayes DN, Zheng Y, Major MB, Weissman BE. Loss of SWI/SNF chromatin remodeling alters NRF2 signaling in non-small cell lung carcinoma. Molecular Cancer Research : McR. PMID 32855269 DOI: 10.1158/1541-7786.Mcr-20-0082 |
0.623 |
|
| 2020 |
Soldi R, Ghosh Halder T, Weston A, Thode T, Drenner K, Lewis R, Kaadige MR, Srivastava S, Daniel Ampanattu S, Rodriguez Del Villar R, Lang J, Vankayalapati H, Weissman B, Trent JM, Hendricks WPD, et al. The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer. Plos One. 15: e0235705. PMID 32649682 DOI: 10.1371/Journal.Pone.0235705 |
0.498 |
|
| 2020 |
Bowman BM, Montgomery SA, Schrank TP, Simon JM, Ptacek TS, Tamir TY, Muvlaney KM, Weir SJ, Nguyen TT, Murphy RM, Makowski L, Hayes DN, Chen XL, Randell SH, Weissman BE, et al. A conditional mouse expressing an activating mutation in NRF2 displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissue. The Journal of Pathology. PMID 32619021 DOI: 10.1002/Path.5504 |
0.433 |
|
| 2020 |
Tamir TY, Bowman BM, Agajanian MJ, Goldfarb D, Schrank TP, Stohrer T, Hale AE, Siesser PF, Weir SJ, Murphy RM, LaPak KM, Weissman BE, Moorman NJ, Major MB. Gain-of-function genetic screen of the kinome reveals BRSK2 as an inhibitor of the NRF2 transcription factor. Journal of Cell Science. PMID 32546533 DOI: 10.1242/Jcs.241356 |
0.332 |
|
| 2020 |
Ji JX, Cochrane DR, Tessier-Cloutier B, Chen SY, Ho G, Pathak KV, Alcazar IN, Farnell D, Leung S, Cheng A, Chow C, Colborne S, Negri GL, Kommoss F, Karnezis A, ... ... Weissman BE, et al. Arginine depletion therapy with ADI-PEG20 limits tumor growth in argininosuccinate synthase deficient ovarian cancer, including small cell carcinoma of the ovary, hypercalcemic type. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32409304 DOI: 10.1158/1078-0432.Ccr-19-1905 |
0.433 |
|
| 2020 |
Tischkowitz M, Huang S, Banerjee S, Hague J, Hendricks WPD, Huntsman DG, Lang JD, Orlando KA, Oza AM, Pautier P, Ray-Coquard I, Trent JM, Wichter M, Witkowski L, McCluggage WG, ... ... Weissman BE, et al. Small Cell Carcinoma of the Ovary, Hypercalcaemic Type - genetics, new treatment targets and current management guidelines. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32156746 DOI: 10.1158/1078-0432.Ccr-19-3797 |
0.387 |
|
| 2020 |
Hamad SH, Montgomery S, Bowman B, Murphy R, Major B, Weissman B. Abstract 1628: Activation of the Nrf2E79Q mutation in mouse lung accelerate development of lung squamous dysplasia Cancer Research. 80: 1628-1628. DOI: 10.1158/1538-7445.Am2020-1628 |
0.433 |
|
| 2020 |
Wang Y, Ong D, Chen SY, Li E, Orlando K, Raupach E, Ji J, Weissman B, Pirrotte P, Humtsman D. Abstract 1459: Selective killing of SMARCA4-deficient gynecologic cancers by mitochondria oxidative phosphorylation inhibitors Cancer Research. 80: 1459-1459. DOI: 10.1158/1538-7445.Am2020-1459 |
0.467 |
|
| 2019 |
Orlando KA, Nguyen V, Raab JR, Walhart T, Weissman BE. Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities. Expert Review of Anticancer Therapy. PMID 30986130 DOI: 10.1080/14737140.2019.1605905 |
0.458 |
|
| 2019 |
Cloer EW, Goldfarb D, Schrank TP, Weissman BE, Major MB. NRF2 Activation in Cancer: From DNA to Protein. Cancer Research. PMID 30760522 DOI: 10.1158/0008-5472.Can-18-2723 |
0.358 |
|
| 2018 |
Gao Y, Kardos J, Yang Y, Tamir TY, Mutter-Rottmayer E, Weissman B, Major MB, Kim WY, Vaziri C. The Cancer/Testes (CT) Antigen HORMAD1 promotes Homologous Recombinational DNA Repair and Radioresistance in Lung adenocarcinoma cells. Scientific Reports. 8: 15304. PMID 30333500 DOI: 10.1038/S41598-018-33601-W |
0.415 |
|
| 2018 |
Wang Y, Chen SY, Colborne S, Lambert G, Shin CY, Dos Santos N, Orlando KA, Lang JD, Hendricks WPD, Bally MB, Karnezis AN, Hass R, Underhill TM, Morin GB, Trent JM, ... Weissman BE, et al. Histone deacetylase inhibitors synergizes with catalytic inhibitors of EZH2 to exhibit anti-tumor activity in small cell carcinoma of the ovary, hypercalcemic type. Molecular Cancer Therapeutics. PMID 30232145 DOI: 10.1158/1535-7163.Mct-18-0348 |
0.521 |
|
| 2018 |
Kuwahara Y, Kennedy LM, Karnezis AN, Mora-Blanco EL, Rogers AB, Fletcher CD, Huntsman DG, Roberts CWM, Rathmell WK, Weissman BE. High Frequency of Ovarian Cyst Development in Vhl;Snf5 Mice. The American Journal of Pathology. PMID 29684361 DOI: 10.1016/J.Ajpath.2018.03.010 |
0.476 |
|
| 2018 |
Lang JD, Hendricks WPD, Orlando KA, Yin H, Kiefer J, Ramos P, Sharma R, Pirrotte P, Raupach EA, Sereduk C, Tang N, Liang WS, Washington M, Facista SJ, Zismann VL, ... ... Weissman BE, et al. Ponatinib shows potent antitumor activity in small cell carcinoma of the ovary hypercalcemic type (SCCOHT) through multi-kinase inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29440177 DOI: 10.1158/1078-0432.Ccr-17-1928 |
0.364 |
|
| 2018 |
Wang Y, Chen SY, Colborne S, Orlando K, Lang J, Karnezis A, Hendricks W, Morin G, Weissman B, Trent J, Huntsman D. Abstract 3673: Targeting the epigenome of small cell hypercalcemic carcinoma of the ovary, hypercalcemic type (SCCOHT) Cancer Research. 78: 3673-3673. DOI: 10.1158/1538-7445.Am2018-3673 |
0.471 |
|
| 2017 |
Wang Y, Chen SY, Karnezis AN, Colborne S, Santos ND, Lang JD, Hendricks WPD, Orlando KA, Yap D, Kommoss F, Bally MB, Morin GB, Trent JM, Weissman BE, Huntsman DG. The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcemic type. The Journal of Pathology. PMID 28444909 DOI: 10.1002/Path.4912 |
0.571 |
|
| 2017 |
Lang JD, Hendricks W, Ramos P, Yin H, Sereduk C, Kiefer J, Wang Y, Karnezis AN, Weissman B, Huntsman D, Trent J. Abstract 1238: Targeting the platelet derived growth factor receptor (PDGFR) with the receptor tyrosine kinase inhibitor ponatinib in small cell carcinoma of the ovary, hypercalcemic type Cancer Research. 77: 1238-1238. DOI: 10.1158/1538-7445.Am2017-1238 |
0.506 |
|
| 2016 |
Karnezis AN, Wang Y, Ramos P, Hendricks W, Yin H, Oliva E, D'Angelo E, Prat J, Nucci MR, Nielsen TO, Weissman BE, Trent JM, Gilks CB, Huntsman DG. Abstract A33: Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcemic type. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-A33 |
0.552 |
|
| 2015 |
Karnezis AN, Wang Y, Ramos P, Hendricks WP, Oliva E, D'Angelo E, Prat J, Nucci MR, Nielsen TO, Chow C, Leung S, Kommoss F, Kommoss S, Silva A, Ronnett BM, ... ... Weissman BE, et al. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcemic type. The Journal of Pathology. PMID 26356327 DOI: 10.1002/Path.4633 |
0.491 |
|
| 2015 |
Weingart MF, Roth JJ, Hutt-Cabezas M, Busse TM, Kaur H, Price A, Maynard R, Rubens J, Taylor I, Mao XG, Xu J, Kuwahara Y, Allen SJ, Erdreich-Epstein A, Weissman BE, et al. Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target. Oncotarget. 6: 3165-77. PMID 25638158 DOI: 10.18632/Oncotarget.3078 |
0.558 |
|
| 2015 |
Kaur H, Hütt-Cabezas M, Weingart MF, Xu J, Kuwahara Y, Erdreich-Epstein A, Weissman BE, Eberhart CG, Raabe EH. The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity. Journal of Neuropathology and Experimental Neurology. 74: 177-85. PMID 25575139 DOI: 10.1097/Nen.0000000000000161 |
0.526 |
|
| 2015 |
Wei D, Charboneau A, Chung H, Sakellariou-Thompson D, Davies B, Simpson DA, Kuwahara Y, Kaufmann WK, Roberts CWM, Weissman BE. Abstract 4787: Cyclin G2, a novel target of the SNF5/BAF47 tumor suppressor gene Cancer Research. 75: 4787-4787. DOI: 10.1158/1538-7445.Am2015-4787 |
0.615 |
|
| 2014 |
Biegel JA, Busse TM, Weissman BE. SWI/SNF chromatin remodeling complexes and cancer. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. 166: 350-66. PMID 25169151 DOI: 10.1002/Ajmg.C.31410 |
0.484 |
|
| 2014 |
Orvis T, Hepperla A, Walter V, Song S, Simon J, Parker J, Wilkerson MD, Desai N, Major MB, Hayes DN, Davis IJ, Weissman B. BRG1/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization. Cancer Research. 74: 6486-98. PMID 25115300 DOI: 10.1158/0008-5472.Can-14-0061 |
0.465 |
|
| 2014 |
Wei D, Goldfarb D, Song S, Cannon C, Yan F, Sakellariou-Thompson D, Emanuele M, Major MB, Weissman BE, Kuwahara Y. SNF5/INI1 deficiency redefines chromatin remodeling complex composition during tumor development. Molecular Cancer Research : McR. 12: 1574-85. PMID 25009291 DOI: 10.1158/1541-7786.Mcr-14-0005 |
0.667 |
|
| 2014 |
Song S, Walter V, Karaca M, Li Y, Bartlett CS, Smiraglia DJ, Serber D, Sproul CD, Plass C, Zhang J, Hayes DN, Zheng Y, Weissman BE. Gene silencing associated with SWI/SNF complex loss during NSCLC development. Molecular Cancer Research : McR. 12: 560-70. PMID 24445599 DOI: 10.1158/1541-7786.Mcr-13-0427 |
0.712 |
|
| 2014 |
Wei D, Chung H, Simpson DA, Kaufmann WK, Weissman BE. Abstract 2245: Mechanism of replicative senescence induced by SNF5 loss Cancer Research. 74: 2245-2245. DOI: 10.1158/1538-7445.Am2014-2245 |
0.666 |
|
| 2014 |
Kuwahara Y, Wei D, Song S, Cannon C, Sakellariou-Thompson D, Emanuele M, Hosoi H, Weissman BE. SNF5/INI1 Deficiency Destabilizes the SWI/SNF Complex During Malignant Rhabdoid Tumor Development Cancer Genetics. 207: 445. DOI: 10.1016/J.Cancergen.2014.09.007 |
0.624 |
|
| 2013 |
Kuwahara Y, Wei D, Durand J, Weissman BE. SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters. Molecular Cancer Research : McR. 11: 251-60. PMID 23364536 DOI: 10.1158/1541-7786.Mcr-12-0390 |
0.723 |
|
| 2013 |
Kuwahara Y, Mora-Blanco EL, Banine F, Rogers AB, Fletcher C, Sherman LS, Roberts CW, Weissman BE. Establishment and characterization of MRT cell lines from genetically engineered mouse models and the influence of genetic background on their development. International Journal of Cancer. Journal International Du Cancer. 132: 2767-77. PMID 23197309 DOI: 10.1002/Ijc.27976 |
0.477 |
|
| 2013 |
Wei D, Weissman BE, Kuwahara Y. Abstract 3821: Elucidating the role of PBRM1 in SNF5 regulated gene expression in malignant rhadboid tumors. Cancer Research. 73: 3821-3821. DOI: 10.1158/1538-7445.Am2013-3821 |
0.724 |
|
| 2013 |
Song S, Orvis T, Zheng Y, Major MB, Weissman BE. Abstract 1299: KEAP1-NRF2-ARE signaling interacts with the SWI/SNF chromatin remodeling complex in non-small cell lung cancer. Cancer Research. 73: 1299-1299. DOI: 10.1158/1538-7445.Am2013-1299 |
0.45 |
|
| 2012 |
Kuwahara Y, Mora-Blanco EL, Rogers A, Fletcher CD, Roberts CW, Weissman BE. Abstract 1359: Establishment and characterization of mouse malignant rhabdoid tumor cell lines Cancer Research. 72: 1359-1359. DOI: 10.1158/1538-7445.Am2012-1359 |
0.535 |
|
| 2011 |
DelBove J, Rosson G, Strobeck M, Chen J, Archer TK, Wang W, Knudsen ES, Weissman BE. Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene. Epigenetics. 6: 1444-53. PMID 22139574 DOI: 10.4161/Epi.6.12.18492 |
0.793 |
|
| 2011 |
Bartlett C, Orvis TJ, Rosson GS, Weissman BE. BRG1 mutations found in human cancer cell lines inactivate Rb-mediated cell-cycle arrest. Journal of Cellular Physiology. 226: 1989-97. PMID 21520050 DOI: 10.1002/Jcp.22533 |
0.704 |
|
| 2011 |
Davies B, Kuwahara Y, Charboneau A, Weissman B. Abstract 4028: Identification of novel binding targets of hSNF5 in malignant rhabdoid tumors Cancer Research. 71: 4028-4028. DOI: 10.1158/1538-7445.Am2011-4028 |
0.583 |
|
| 2011 |
Kuwahara Y, Durand J, Weissman BE. Abstract 212: Reexpression of hSNF5 regulates the transcriptional activity of the NOXA promoter through p53 independent mechanisms in malignant rhabdoid tumors Cellular and Molecular Biology. 71: 212-212. DOI: 10.1158/1538-7445.Am2011-212 |
0.465 |
|
| 2010 |
Cohen SM, Chastain PD, Rosson GB, Groh BS, Weissman BE, Kaufman DG, Bultman SJ. BRG1 co-localizes with DNA replication factors and is required for efficient replication fork progression. Nucleic Acids Research. 38: 6906-19. PMID 20571081 DOI: 10.1093/Nar/Gkq559 |
0.416 |
|
| 2010 |
Kuwahara Y, Charboneau A, Knudsen ES, Weissman BE. Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism. Cancer Research. 70: 1854-65. PMID 20179200 DOI: 10.1158/0008-5472.Can-09-1922 |
0.477 |
|
| 2009 |
Weissman B, Knudsen KE. Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer. Cancer Research. 69: 8223-30. PMID 19843852 DOI: 10.1158/0008-5472.Can-09-2166 |
0.43 |
|
| 2009 |
DelBove J, Kuwahara Y, Mora-Blanco EL, Godfrey V, Funkhouser WK, Fletcher CD, Van Dyke T, Roberts CW, Weissman BE. Inactivation of SNF5 cooperates with p53 loss to accelerate tumor formation in Snf5(+/-);p53(+/-) mice. Molecular Carcinogenesis. 48: 1139-48. PMID 19676100 DOI: 10.1002/Mc.20568 |
0.763 |
|
| 2008 |
Shen H, Powers N, Saini N, Comstock CE, Sharma A, Weaver K, Revelo MP, Gerald W, Williams E, Jessen WJ, Aronow BJ, Rosson G, Weissman B, Muchardt C, Yaniv M, et al. The SWI/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer. Cancer Research. 68: 10154-62. PMID 19074882 DOI: 10.1158/0008-5472.Can-08-1794 |
0.354 |
|
| 2007 |
Chai J, Lu X, Godfrey V, Fletcher C, Roberts CW, Van Dyke T, Weissman BE. Tumor-specific cooperation of retinoblastoma protein family and Snf5 inactivation. Cancer Research. 67: 3002-9. PMID 17409406 DOI: 10.1158/0008-5472.Can-06-4207 |
0.654 |
|
| 2006 |
De Clerck YA, Weissman BE, Yu D, Parsons R, Bar-Eli M, Roy-Burman P, Seewaldt VL, Cress AE, Languino LR, Batra SK, Tang CK, Sheng S, Chen WT, Chellappan S, Cheng SY, et al. Tumor progression and metastasis from genetic to microenvironmental determinants: a workshop of the tumor progression and metastasis NIH study section in honor of Dr. Martin L. Padarathsingh, May 31, 2006, Georgetown, Washington, DC. Cancer Biology & Therapy. 5: 1588-99. PMID 17224636 DOI: 10.4161/Cbt.5.12.3660 |
0.383 |
|
| 2006 |
Charboneau A, Chai J, Jordan J, Funkhouser W, Judkins A, Biegel J, Weissman B. P-Akt expression distinguishes two types of malignant rhabdoid tumors. Journal of Cellular Physiology. 209: 422-7. PMID 16897758 DOI: 10.1002/Jcp.20737 |
0.708 |
|
| 2005 |
Chai J, Charboneau AL, Betz BL, Weissman BE. Loss of the hSNF5 gene concomitantly inactivates p21CIP/WAF1 and p16INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells. Cancer Research. 65: 10192-8. PMID 16288006 DOI: 10.1158/0008-5472.Can-05-1896 |
0.787 |
|
| 2005 |
Rosson GB, Bartlett C, Reed W, Weissman BE. BRG1 loss in MiaPaCa2 cells induces an altered cellular morphology and disruption in the organization of the actin cytoskeleton. Journal of Cellular Physiology. 205: 286-94. PMID 15887247 DOI: 10.1002/Jcp.20397 |
0.738 |
|
| 2005 |
Banine F, Bartlett C, Gunawardena R, Muchardt C, Yaniv M, Knudsen ES, Weissman BE, Sherman LS. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation. Cancer Research. 65: 3542-7. PMID 15867346 DOI: 10.1158/0008-5472.Can-04-3554 |
0.685 |
|
| 2005 |
Link KA, Burd CJ, Williams E, Marshall T, Rosson G, Henry E, Weissman B, Knudsen KE. BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF Molecular and Cellular Biology. 25: 2200-2215. PMID 15743818 DOI: 10.1128/Mcb.25.6.2200-2215.2005 |
0.313 |
|
| 2005 |
Reisman DN, Sciarrotta J, Bouldin TW, Weissman BE, Funkhouser WK. The expression of the SWI/SNF ATPase subunits BRG1 and BRM in normal human tissues. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 13: 66-74. PMID 15722796 DOI: 10.1097/00129039-200503000-00011 |
0.523 |
|
| 2004 |
Rorie CJ, Weissman BE. The Ews/Fli-1 fusion gene changes the status of p53 in neuroblastoma tumor cell lines. Cancer Research. 64: 7288-95. PMID 15492248 DOI: 10.1158/0008-5472.Can-04-1610 |
0.815 |
|
| 2004 |
Rorie CJ, Thomas VD, Chen P, Pierce HH, O'Bryan JP, Weissman BE. The Ews/Fli-1 fusion gene switches the differentiation program of neuroblastomas to Ewing sarcoma/peripheral primitive neuroectodermal tumors. Cancer Research. 64: 1266-77. PMID 14973077 DOI: 10.1158/0008-5472.Can-03-3274 |
0.788 |
|
| 2003 |
Padalecki SS, Weldon KS, Reveles XT, Buller CL, Grubbs B, Cui Y, Yin JJ, Hall DC, Hummer BT, Weissman BE, Dallas M, Guise TA, Leach RJ, Johnson-Pais TL. Chromosome 18 suppresses prostate cancer metastases. Urologic Oncology. 21: 366-73. PMID 14670546 DOI: 10.1016/S1078-1439(03)00013-9 |
0.784 |
|
| 2003 |
Betz BL, Weissman BE. Hybrid capture of putative tumor suppressor genes. Methods in Molecular Biology (Clifton, N.J.). 222: 365-73. PMID 12710698 DOI: 10.1385/1-59259-328-3:365 |
0.723 |
|
| 2003 |
Reisman DN, Sciarrotta J, Wang W, Funkhouser WK, Weissman BE. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Research. 63: 560-6. PMID 12566296 |
0.411 |
|
| 2003 |
Hummer BT, Bartlett C, Henry E, Weissman BE. Expression of Smad4 in the FaDu cell line partially restores TGF-beta growth inhibition but is not sufficient to regulate fibronectin expression or suppress tumorigenicity. Journal of Cellular Physiology. 194: 289-302. PMID 12548549 DOI: 10.1002/Jcp.10202 |
0.755 |
|
| 2002 |
Betz BL, Strobeck MW, Reisman DN, Knudsen ES, Weissman BE. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB. Oncogene. 21: 5193-203. PMID 12149641 DOI: 10.1038/Sj.Onc.1205706 |
0.77 |
|
| 2002 |
Reisman DN, Strobeck MW, Betz BL, Sciariotta J, Funkhouser W, Murchardt C, Yaniv M, Sherman LS, Knudsen ES, Weissman BE. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression. Oncogene. 21: 1196-207. PMID 11850839 DOI: 10.1038/sj.onc.1205188 |
0.774 |
|
| 2002 |
Biegel JA, Kalpana G, Knudsen ES, Packer RJ, Roberts CW, Thiele CJ, Weissman B, Smith M. The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors. Cancer Research. 62: 323-8. PMID 11782395 |
0.327 |
|
| 2002 |
Strobeck MW, Reisman DN, Gunawardena RW, Betz BL, Angus SP, Knudsen KE, Kowalik TF, Weissman BE, Knudsen ES. Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling. The Journal of Biological Chemistry. 277: 4782-9. PMID 11719516 DOI: 10.1074/Jbc.M109532200 |
0.76 |
|
| 2001 |
Xu XL, Wu LC, Du F, Davis A, Peyton M, Tomizawa Y, Maitra A, Tomlinson G, Gazdar AF, Weissman BE, Bowcock AM, Baer R, Minna JD. Inactivation of human SRBC, located within the 11p15.5-P15.4 tumor suppressor region, in breast and lung cancers Cancer Research. 61: 7943-7949. PMID 11691816 |
0.423 |
|
| 2001 |
Dauphinot L, De Oliveira C, Melot T, Sevenet N, Thomas V, Weissman BE, Delattre O. Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2 and c-Myc expression Oncogene. 20: 3258-3265. PMID 11423975 DOI: 10.1038/Sj.Onc.1204437 |
0.809 |
|
| 2001 |
Decristofaro MF, Betz BL, Rorie CJ, Reisman DN, Wang W, Weissman BE. Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies. Journal of Cellular Physiology. 186: 136-45. PMID 11147808 DOI: 10.1002/1097-4652(200101)186:1<136::Aid-Jcp1010>3.0.Co;2-4 |
0.811 |
|
| 2001 |
Strobeck MW, DeCristofaro MF, Banine F, Weissman BE, Sherman LS, Knudsen ES. The BRG-1 subunit of the SWI/SNF complex regulates CD44 expression. The Journal of Biological Chemistry. 276: 9273-8. PMID 11108719 DOI: 10.1074/Jbc.M009747200 |
0.39 |
|
| 2000 |
Merrihew RV, Cruickshank RD, Conway K, Weissman BE. Altered response of a human squamous cell carcinoma cell line to 1,25-dihydroxyvitamin D3 after transfer of a normal chromosome 11 Experimental Cell Research. 259: 191-203. PMID 10942591 DOI: 10.1006/Excr.2000.4946 |
0.421 |
|
| 2000 |
Strobeck MW, Knudsen KE, Fribourg AF, DeCristofaro MF, Weissman BE, Imbalzano AN, Knudsen ES. BRG-1 is required for RB-mediated cell cycle arrest. Proceedings of the National Academy of Sciences of the United States of America. 97: 7748-53. PMID 10884406 DOI: 10.1073/Pnas.97.14.7748 |
0.526 |
|
| 2000 |
Miele ME, Jewett MD, Goldberg SF, Hyatt DL, Morelli C, Gualandi F, Rimessi P, Hicks DJ, Weissman BE, Barbanti-Brodano G, Welch DR. A human melanoma metastasis-suppressor locus maps to 6q16.3-q23 International Journal of Cancer. 86: 524-528. PMID 10797266 DOI: 10.1002/(Sici)1097-0215(20000515)86:4<524::Aid-Ijc13>3.0.Co;2-W |
0.39 |
|
| 1999 |
DeCristofaro MF, Betz BL, Wang W, Weissman BE. Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors. Oncogene. 18: 7559-65. PMID 10602515 DOI: 10.1038/Sj.Onc.1203168 |
0.779 |
|
| 1999 |
Mayo MW, Wang CY, Drouin SS, Madrid LV, Marshall AF, Reed JC, Weissman BE, Baldwin AS. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene. The Embo Journal. 18: 3990-4003. PMID 10406804 DOI: 10.1093/Emboj/18.14.3990 |
0.58 |
|
| 1999 |
Isfort RJ, Cody DB, Lovell GJ, Gioeli D, Weissman BE, Doersen CJ. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids Molecular Carcinogenesis. 25: 30-41. PMID 10331742 DOI: 10.1002/(Sici)1098-2744(199905)25:1<30::Aid-Mc4>3.0.Co;2-N |
0.502 |
|
| 1999 |
Coleman WB, Ricketts SL, Borchert KM, Presnell SC, Esch GL, McCullough KD, Weissman BE, Smith GJ, Grisham JW. Induction of rat WT1 gene expression correlates with human chromosome 11p11.2-p12-mediated suppression of tumorigenicity in rat liver epithelial tumor cell lines. International Journal of Oncology. 14: 957-63. PMID 10200348 DOI: 10.3892/Ijo.14.5.957 |
0.555 |
|
| 1999 |
Isaacs JS, Barrett JC, Weissman BE. Interference of proteins involved in the cytoplasmic sequestration of p53 with human papillomavirus E6-mediated degradation. Molecular Carcinogenesis. 24: 70-7. PMID 10029413 DOI: 10.1002/(Sici)1098-2744(199901)24:1<70::Aid-Mc10>3.0.Co;2-5 |
0.369 |
|
| 1998 |
West A, Vojta PJ, Welch DR, Weissman BE. Chromosome localization and genomic structure of the KiSS-1 metastasis suppressor gene (KISS1) Genomics. 54: 145-148. PMID 9806840 DOI: 10.1006/Geno.1998.5566 |
0.384 |
|
| 1998 |
Isaacs JS, Hardman R, Carman TA, Barrett JC, Weissman BE. Differential subcellular p53 localization and function in N- and S-type neuroblastoma cell lines Cell Growth and Differentiation. 9: 545-555. PMID 9690622 |
0.308 |
|
| 1998 |
Cooper PR, Smilinich NJ, Day CD, Nowak NJ, Reid LH, Pearsall RS, Reece M, Prawitt D, Landers J, Housman DE, Winterpacht A, Zabel BU, Pelletier J, Weissman BE, Shows TB, et al. Divergently transcribed overlapping genes expressed in liver and kidney and located in the 11p15.5 imprinted domain. Genomics. 49: 38-51. PMID 9570947 DOI: 10.1006/Geno.1998.5221 |
0.46 |
|
| 1998 |
Phillips KK, White AE, Hicks DJ, Welch DR, Barrett JC, Wei LL, Weissman BE. Correlation between reduction of metastasis in the MDA-MB-435 model system and increased expression of the Kai-1 protein. Molecular Carcinogenesis. 21: 111-20. PMID 9496911 DOI: 10.1002/(Sici)1098-2744(199802)21:2<111::Aid-Mc5>3.0.Co;2-Q |
0.512 |
|
| 1997 |
Yang X, Welch DR, Phillips KK, Weissman BE, Wei LL. KAI1, a putative marker for metastatic potential in human breast cancer. Cancer Letters. 119: 149-55. PMID 9570365 DOI: 10.1016/S0304-3835(97)00273-5 |
0.417 |
|
| 1997 |
Crider-Miller SJ, Reid LH, Higgins MJ, Nowak NJ, Shows TB, Futreal PA, Weissman BE. Novel transcribed sequences within the BWS/WT2 region in 11p15.5: tissue-specific expression correlates with cancer type. Genomics. 46: 355-63. PMID 9441738 DOI: 10.1006/Geno.1997.5061 |
0.517 |
|
| 1997 |
Hall IJ, Gioeli D, Weissman BE, Tlsty TD. Identification of additional complementation groups that regulate genomic instability Genes Chromosomes and Cancer. 20: 103-112. PMID 9331561 DOI: 10.1002/(Sici)1098-2264(199710)20:2<103::Aid-Gcc1>3.0.Co;2-7 |
0.555 |
|
| 1997 |
Rodriguez P, Munroe D, Prawitt D, Chu LL, Bric E, Kim J, Reid LH, Davies C, Nakagama H, Loebbert R, Winterpacht A, Petruzzi MJ, Higgins MJ, Nowak N, Evans G, ... ... Weissman BE, et al. Functional characterization of human nucleosome assembly protein-2 (NAP1L4) suggests a role as a histone chaperone. Genomics. 44: 253-65. PMID 9325046 DOI: 10.1006/Geno.1997.4868 |
0.439 |
|
| 1997 |
Coleman WB, Esch GL, Borchert KM, McCullough KD, Reid LH, Weissman BE, Smith GJ, Grisham JW. Localization of a putative liver tumor suppressor locus to a 950-kb region of human 11p11.2-p12 using rat liver tumor microcell hybrid cell lines. Molecular Carcinogenesis. 19: 267-72. PMID 9290704 DOI: 10.1002/(Sici)1098-2744(199708)19:4<267::Aid-Mc8>3.0.Co;2-9 |
0.511 |
|
| 1997 |
Reid LH, Davies C, Cooper PR, Crider-Miller SJ, Sait SN, Nowak NJ, Evans G, Stanbridge EJ, deJong P, Shows TB, Weissman BE, Higgins MJ. A 1-Mb physical map and PAC contig of the imprinted domain in 11p15.5 that contains TAPA1 and the BWSCR1/WT2 region. Genomics. 43: 366-75. PMID 9268640 DOI: 10.1006/Geno.1997.4826 |
0.483 |
|
| 1997 |
Isaacs JS, Chen P, Garza A, Hansen MF, Barrett JC, Weissman BE. Failure of HPV E6 to rapidly degrade p53 in human HeLa x PNET cell hybrids. Oncogene. 14: 1669-78. PMID 9135068 DOI: 10.1038/Sj.Onc.1201001 |
0.367 |
|
| 1997 |
Gioeli D, Conway K, Weissman BE. Localization and characterization of a chromosome 11 tumor suppressor gene using organotypic raft cultures Cancer Research. 57: 1157-1165. PMID 9067287 |
0.417 |
|
| 1996 |
Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, Welch DR. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene Journal of the National Cancer Institute. 88: 1731-1737. PMID 8944003 DOI: 10.1093/Jnci/88.23.1731 |
0.511 |
|
| 1996 |
Reid LH, West A, Gioeli DG, Phillips KK, Kelleher KF, Araujo D, Stanbridge EJ, Dowdy SF, Gerhard DS, Weissman BE. Localization of a tumor suppressor gene in 11p15.5 using the G401 Wilms' tumor assay. Human Molecular Genetics. 5: 239-47. PMID 8824880 DOI: 10.1093/Hmg/5.2.239 |
0.531 |
|
| 1996 |
Phillips KK, Welch DR, Miele ME, Lee JH, Wei LL, Weissman BE. Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11. Cancer Research. 56: 1222-7. PMID 8640802 |
0.325 |
|
| 1996 |
Orlow I, Iavarone A, Crider-Miller SJ, Bonilla F, Latres E, Lee MH, Gerald WL, Massagué J, Weissman BE, Cordón-Cardó C. Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms' tumors Cancer Research. 56: 1219-1221. PMID 8640801 |
0.416 |
|
| 1996 |
Reid LH, Crider-Miller SJ, West A, Lee MH, Massagué J, Weissman BE. Genomic organization of the human p57KIP2 gene and its analysis in the G401 Wilms' tumor assay Cancer Research. 56: 1214-1218. PMID 8640800 |
0.442 |
|
| 1996 |
Weissman BE, Gioeli D, Phillips K. Identification of tumor suppressor genes by microcell hybridization Methods: a Companion to Methods in Enzymology. 9: 38-46. DOI: 10.1006/Meth.1996.0006 |
0.573 |
|
| 1995 |
McMaster ML, Gessler M, Stanbridge EJ, Weissman BE. WT1 expression alters tumorigenicity of the G401 kidney-derived cell line Cell Growth and Differentiation. 6: 1609-1617. PMID 9019166 |
0.495 |
|
| 1995 |
Chen P, Lin HH, Weissman BE. A functional analysis of tumor suppressor activity for peripheral neuroepitheliomas by monochromosome transfer Oncogene. 10: 577-586. PMID 7845683 |
0.455 |
|
| 1995 |
Jiang H, Lin J, Su ZZ, Herlyn M, Kerbel RS, Weissman BE, Welch DR, Fisher PB. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells Oncogene. 10: 1855-1864. PMID 7753561 |
0.397 |
|
| 1995 |
Coleman WB, McCullough KD, Esch GL, Civalier CJ, Livanos E, Weissman BE, Grisham JW, Smith GJ. Suppression of the tumorigenic phenotype of a rat liver epithelial tumor cell line by the p11.2-p12 region of human chromosome 11 Molecular Carcinogenesis. 13: 220-232. PMID 7646761 DOI: 10.1002/Mc.2940130405 |
0.536 |
|
| 1995 |
Weissman BE, Conway K. Genetic aspects of tumor suppressor genes Advances in Genome Biology. 3: 143-162. DOI: 10.1016/S1067-5701(06)80006-9 |
0.42 |
|
| 1994 |
Welch DR, Chen P, Miele ME, McGary CT, Bower JM, Stanbridge EJ, Weissman BE. Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene. 9: 255-62. PMID 8302587 |
0.311 |
|
| 1994 |
Chen P, Ellmore N, Weissman BE. Functional evidence for a second tumor suppressor gene on human chromosome 17 Molecular and Cellular Biology. 14: 534-542. PMID 8264622 DOI: 10.1128/Mcb.14.1.534 |
0.581 |
|
| 1992 |
Conway K, Morgan D, Phillips KK, Yuspa SH, Weissman BE. Tumorigenic suppression of a human cutaneous squamous cell carcinoma cell line in the nude mouse skin graft assay. Cancer Research. 52: 6487-95. PMID 1358434 |
0.346 |
|
| 1992 |
Loh WE, Scrable HJ, Livanos E, Arboleda MJ, Cavenee WK, Oshimura M, Weissman BE. Human chromosome 11 contains two different growth suppressor genes for embryonal rhabdomyosarcoma Proceedings of the National Academy of Sciences of the United States of America. 89: 1755-1759. PMID 1347425 DOI: 10.1073/Pnas.89.5.1755 |
0.474 |
|
| 1992 |
Parshad R, Price FM, Oshimura M, Barrett JC, Satoh H, Weissman BE, Stanbridge EJ, Sanford KK. Complementation of a DNA repair deficiency in six human tumor cell lines by chromosome 11. Human Genetics. 88: 524-8. PMID 1312990 DOI: 10.1007/Bf00219338 |
0.516 |
|
| 1991 |
Dowdy SF, Lai Km, Weissman BE, Matsui Y, Hogan BLM, Stanbridge EJ. The isolation and characterization of a novel cDNA demonstrating an altered mRNA level in nontumorigenic wilms' microcell hybrid cells Nucleic Acids Research. 19: 5763-5769. PMID 1658743 DOI: 10.1093/Nar/19.20.5763 |
0.491 |
|
| 1991 |
Dowdy SF, Fasching CL, Araujo D, Lai KM, Livanos E, Weissman BE, Stanbridge EJ. Suppression of tumorigenicity in wilms tumor by the p15.5-p14 region of chromosome 11 Science. 254: 293-295. PMID 1656527 DOI: 10.1126/Science.1656527 |
0.497 |
|
| 1991 |
Dowdy SF, Weissman BE, Stanbridge EJ. Correlation of the inability to sustain growth in defined serum-free medium with the suppression of tumorigenicity in Wilms' nephroblastoma Journal of Cellular Physiology. 147: 248-255. PMID 1645741 DOI: 10.1002/Jcp.1041470209 |
0.432 |
|
| 1990 |
Chen P, Weissman BE. A complementation analysis of suppression of tumorigenicity in human tumor cell hybrids Progress in Clinical and Biological Research. 340: 13-20. PMID 2196575 |
0.409 |
|
| 1990 |
Weissman BE. Genetic behaviour of tumorigenicity in human cancer Cancer Surveys. 9: 475-485. PMID 1983209 |
0.301 |
|
| 1989 |
Weissman BE, Arboleda MJ, Kimoto KA, Macdonald MJ, Ochiai R, Der CJ. Activation of ras oncogenes in chemically transformed BALB/MK‐2 mouse keratinocytes Molecular Carcinogenesis. 2: 150-158. PMID 2506887 DOI: 10.1002/Mc.2940020308 |
0.313 |
|
| 1989 |
Karnes P, Tran T, Ho H, Boquiren D, Cui M, Weissman B, Bogenmann E, Isaacs H, Shimada H, Barranger J, Ying K. The establishment of a malignant rhabdoid tumor cell line with a specific chromosomal translocation, t(11p;22q) Cancer Genetics and Cytogenetics. 41: 276-277. DOI: 10.1016/0165-4608(89)90349-X |
0.364 |
|
| 1988 |
Pasquale SR, Jones GR, Doersen CJ, Weissman BE. Tumorigenicity and Oncogene Expression in Pediatric Cancers Cancer Research. 48: 2715-2719. PMID 3359432 |
0.411 |
|
| 1987 |
Weissman BE, Saxon PJ, Pasquale SR, Jones GR, Geiser AG, Stanbridge EJ. Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression Science. 236: 175-180. PMID 3031816 DOI: 10.1126/Science.3031816 |
0.557 |
|
| 1983 |
Weissman BE, Stanbridge EJ. Complexity of control of tumorigenic expression in intraspecies hybrids of human SV40-transformed fibroblasts and normal human fibroblast cell lines Cytogenetics and Cell Genetics. 35: 263-268. PMID 6311488 |
0.315 |
|
| 1982 |
Stanbridge EJ, Der CJ, Doersen CJ, Nishimi RY, Peehl DM, Weissman BE, Wilkinson JE. Human cell hybrids: Analysis of transformation and tumorigenicity Science. 215: 252-259. PMID 7053574 DOI: 10.1126/Science.7053574 |
0.365 |
|
| Show low-probability matches. |